Marker Therapeutics, Inc. (MRKR) financial statements and ratios from SEC XBRL: revenue $3.55M (TTM), net margin -343.0%, revenue growth -86.9% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $3.55M |
| Net Margin | -343.0% |
| Revenue Growth (YoY) | -86.9% |
| EPS Growth (YoY) | -69.0% |
| Price / Book | 1.90 |
| Price / Sales | 7.21 |
| Altman Z-Score | -28.60 (distress) |
| Sector P/E (Healthcare) | 21.7 |
MRKR overview · MRKR earnings · MRKR KPIs · MRKR investor relations · MRKR ownership · MRKR peers · MRKR filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.